BWP
LMAT icon

Balboa Wealth Partners’s LeMaitre Vascular LMAT Stock Holding History

Balboa Wealth Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Sell
2,206
-7
-0.3% -$718 0.03% 433
2026
Q1 		$242K Buy
+2,213
New +$211K 0.04% 357

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Balboa Wealth Partners's LMAT Position: Q2 2026 in Review

Balboa Wealth Partners reduced its LeMaitre Vascular (LMAT) stake by 0.32% in Q2 2026, selling an estimated $718 and leaving 2,206 shares worth $212K. The position accounts for 0.03% of the portfolio, ranked #433.

Balboa Wealth Partners first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $242K in Q1 2026. 259 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Balboa Wealth Partners held 2,206 shares of LeMaitre Vascular worth $212K as of Q2 2026.
  • Balboa Wealth Partners sold 7 LeMaitre Vascular shares in Q2 2026, an estimated $718.
  • LeMaitre Vascular made up 0.03% of Balboa Wealth Partners's portfolio in Q2 2026, its #433 holding.
  • Balboa Wealth Partners first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
  • Balboa Wealth Partners's LeMaitre Vascular position peaked at $242K in Q1 2026.
  • 259 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Balboa Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.